SBIR/STTR Research Award

Protection against UV radiation induced skin damage by methoxylated flavonoids

Award identifier 972841951b1c9d1e867a900db6dcb7d4ff88f14cc9592f96f52d8a7e0a942d32Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BLUEGRASS ADVANCED MATERIALS, LLC
Proposal award date
2017-09-15
Contract end date
2019-08-31
UEI
M9JMGN342NR5
Solicitation number
PA16-302
Topic code
NIEHS

Research abstract

Project Summary In eukaryotic cells ultra violet radiation UVR induces the formation of free radicals which damage cellular lipids proteins and nucleic acids In man this damage can lead to chronic inflammation and skin neoplasias so that compounds which protect cells from UVR are of therapeutic interest Flavonoids are candidates because they protect plant cells by absorbing UVR and acting as free radical scavengers FRS Bluegrass Advanced Materials BAM has licensed a technology from Naprogenix Inc which is based on the discovery that methoxylated flavonoids purified from extracts of a native goldenrod Solidago nemoralis have agonist activity at human alpha nicotinic receptors nicAChRs These receptors inhibit release of inflammatory mediators from skin macrophages which contribute to UV mediated inflammation and carcinogenesis In support collaborative research with the University of Kentucky showed that a flavonoid enriched goldenrod extract potently protected transgenic humanized mice against UVR induced inflammation and damage in vivo However the potential therapeutic and commercial value of this activity is limited by the modest persistence and bioavailability of these flavonoids when applied topically To overcome this drawback BAM will utilize its proprietary technology to convert flavonoids into biodegradable polymer microparticles These slowly release the original flavonoids from the polymer essentially providing an extended release topical preparation with improved bioavailability This phase I application will apply this technology to the methoxylated anti inflammatory flavonoids and evaluate their microparticle preparation for UV protection when administered topically in a mouse model of the fair skinned UV sensitive human The first specific aim is to prepare microparticle polymers of a the flavonoid enriched extract of goldenrod and b pure rhamnetin the methoxylated flavonoid with greatest potency on alpha nicAChRs The second specific aim is to test each of these preparations for their ability to penetrate and protect humanized mouse skin against UVR specifically measuring the tissue content of pro and anti inflammatory mediators and measuring effects on erythema and inflammation The effects of the microparticle polymers will be compared with those of the free flavonoids applied topically in ethanol polyethylene glycol as used previously If as predicted the UVR protectant effects of the flavonoids are enhanced then phase II will aim to a relate efficacy to alpha nicAChR activity using selective antagonists and alpha nicAChR knockout mice b test the effects of chronic use of the preparations on UVR induced changes in mouse skin c develop new ways of producing these flavonoids The ultimate objectives of phase I and II are to develop these methoxylated flavonoid polymer preparations as therapeutic and cosmeceutical agents The intention is to commercialize these products in phase III in partnership with major pharmaceutical and cosmetics companies Project narrative Natural compounds from plants that protect the skin against damage caused by ultraviolet radiation are of commercial value as cosmetics and therapeutic agents This proposal is to begin the development of flavonoids from a native goldenrod for this purpose The main objective of phase I is to demonstrate that the applicants can produce biopolymer formulations of the flavonoids with a greater ability to be absorbed into the skin and with consequently greater protective actions !

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

5 SBIR/STTR records share this UEI (2013–2024). Reported award amounts total $3,120,373. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.